NKGen Biotech, Inc. (NYSE:NKGN – Get Free Report)’s share price was down 3.3% during trading on Wednesday . The stock traded as low as $1.42 and last traded at $1.46. Approximately 140,934 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 2,693,942 shares. The stock had previously closed […]
By Adriano Marchese NKGen Biotech said Wednesday it has received regulatory clearance to begin trials for its cell therapy to treat patients with moderate.
By Adriano Marchese NKGen Biotech shares climbed after the biotechnology company received regulatory clearance in Canada to begin trials for treatment of.
NKGen Biotech, Inc. (NYSE:NKGN – Get Free Report)’s stock price shot up 0.3% during trading on Thursday . The company traded as high as $2.97 and last traded at $2.88. 17,843 shares were traded during mid-day trading, a decline of 83% from the average session volume of 106,903 shares. The stock had previously closed at […]